Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 ST resolution versus Thrombolysis In Myocardial Infarction (TIMI) flow grade. The reperfusion regimens used in the TIMI-14 substudy were tissue plasminogen activator (tPA) and combinations of abciximab plus reduced-dose tPA, whereas the fibrinolytic agent used in Hirudin for Improvement of Thrombolysis study (HIT-4) was streptokinase. p < 0.001 for the correlation between ST resolution and TIMI 3 flow; p < 0.001 for correlation between ST resolution and infarct-related artery patency (TIMI 2 + 3 flow). Adapted from references 37 and 38.
|
